Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

JUN identified as a crucial regulator of pathological skin scarring via CD36

Sep. 15, 2021

Genfleet Therapeutics discovers RIP-1 inhibitors

Sep. 9, 2021

LEO Pharma's novel IL-17A/IL-17AR interaction modulator for the oral treatment of psoriasis

Sep. 3, 2021

New melanocortin receptor modulators presented by Palatin Technologies

Sep. 2, 2021

Phase II study of SHR-0302 in alopecia areata meets primary efficacy endpoint

Aug. 26, 2021

Data presented for Almirall's JAK inhibitor LAS-200019

Aug. 26, 2021

Jupiter Wellness submits pre-IND meeting request for JW-100 for eczema

Aug. 24, 2021

Completed phase I studies of ME-3183 pave way for phase II studies in plaque psoriasis

Aug. 24, 2021

DSG3-CAART cells safe in second cohort of DesCAARTes phase I trial

Aug. 19, 2021

AgeX Therapeutics describes new exosomes for wound healing

Aug. 17, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...